Cargando…
Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer: A Rare Phenomenon?
Complication of leptomeningeal carcinomatosis (LMC) is critical. It causes rapid neurological deterioration, and subsequently, discontinuation of the ineffective treatment even in body tumor dormancy. Large molecular chemotherapeutic agents that are unlikely to penetrate the CSF space, are more like...
Autores principales: | Sayanagi, Taichi, Ohishi, Yumiko, Katayama, Makoto, Tamura, Ryota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317958/ https://www.ncbi.nlm.nih.gov/pubmed/35877817 http://dx.doi.org/10.3390/medicines9070039 |
Ejemplares similares
-
Prolonged Survival and Restored Useful Life by Early Induction of Intrathecal Chemotherapy in a Patient with Leptomeningeal Carcinomatosis from Ovarian Cancer
por: Takahara, Kento, et al.
Publicado: (2022) -
Leptomeningeal Carcinomatosis: A Rare Complication of Metastatic Gastric Cancer
por: Lai, Steven Y, et al.
Publicado: (2023) -
A Report of a Rare Gastric Cancer Case: Leptomeningeal Carcinomatosis
por: Taghizadeh-Kermani, Ali, et al.
Publicado: (2015) -
Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine
por: Ceccon, Garry, et al.
Publicado: (2020) -
Leptomeningeal carcinomatosis in a patient with gallbladder carcinoma
por: Jose, Nisha, et al.
Publicado: (2017)